Discontinued ProductUnfortunately Danazol (Cat. No. 0687) has been withdrawn from sale for commercial reasons.
Anterior pituitary suppressant with weak androgenic effects.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 337.46. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.96 mL||14.82 mL||29.63 mL|
|5 mM||0.59 mL||2.96 mL||5.93 mL|
|10 mM||0.3 mL||1.48 mL||2.96 mL|
|50 mM||0.06 mL||0.3 mL||0.59 mL|
References are publications that support the products' biological activity.
Panidis et al (1994) Danazol influences gonadotropin secretion acting at the hypothalamic level. Int.J.Gynaecol.Obstet. 45 241 PMID: 7926243
Keywords: Danazol, supplier, Anterior, pituitary, suppressant, Peptide, Receptors, Other, Peptide, Receptors, Other, Peptide, Receptors, Tocris Bioscience
Citations for Danazol
Citations are publications that use Tocris products.
Currently there are no citations for Danazol.
Average Rating:(Based on 0 Reviews)
Literature in this Area
Peptides Involved in Appetite Modulation Scientific Review
Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.